US equities
|
SPCX
$166.90
▲+4.99%
NVDA
$236.59
▲+1.13%
MU
$1,062.71
▼-1.13%
TSLA
$377.63
▲+1.90%
MSFT
$526.42
▲+1.72%
SNDK
$1,713.43
▼-0.38%
INTC
$116.70
▼-2.20%
META
$744.92
▲+2.31%
SPCX
$166.90
▲+4.99%
NVDA
$236.59
▲+1.13%
MU
$1,062.71
▼-1.13%
TSLA
$377.63
▲+1.90%
MSFT
$526.42
▲+1.72%
SNDK
$1,713.43
▼-0.38%
INTC
$116.70
▼-2.20%
META
$744.92
▲+2.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Robbins Geller Rudman
BIIB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
June 17, 2024
From
Robbins Geller Rudman
Via
Business Wire
Tickers
BIIB